- Home
- NMRA vs CSPI Comparison
NMRA vs CSPI Comparison
Compare NMRA & CSPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- CSPI
- Stock Information
- Founded
- NMRA 2019
- CSPI 1968
- Country
- NMRA United States
- CSPI United States
- Employees
- NMRA N/A
- CSPI N/A
- Industry
- NMRA
- CSPI EDP Services
- Sector
- NMRA
- CSPI Technology
- Exchange
- NMRA Nasdaq
- CSPI Nasdaq
- Market Cap
- NMRA 121.0M
- CSPI 105.9M
- IPO Year
- NMRA 2023
- CSPI 1987
- Fundamental
- Price
- NMRA $0.84
- CSPI $12.84
- Analyst Decision
- NMRA Buy
- CSPI
- Analyst Count
- NMRA 8
- CSPI 0
- Target Price
- NMRA $9.29
- CSPI N/A
- AVG Volume (30 Days)
- NMRA 1.4M
- CSPI 78.7K
- Earning Date
- NMRA 08-05-2025
- CSPI 08-12-2025
- Dividend Yield
- NMRA N/A
- CSPI 0.93%
- EPS Growth
- NMRA N/A
- CSPI N/A
- EPS
- NMRA N/A
- CSPI N/A
- Revenue
- NMRA N/A
- CSPI $54,955,000.00
- Revenue This Year
- NMRA N/A
- CSPI N/A
- Revenue Next Year
- NMRA N/A
- CSPI N/A
- P/E Ratio
- NMRA N/A
- CSPI N/A
- Revenue Growth
- NMRA N/A
- CSPI N/A
- 52 Week Low
- NMRA $0.61
- CSPI $10.39
- 52 Week High
- NMRA $17.19
- CSPI $21.95
- Technical
- Relative Strength Index (RSI)
- NMRA 52.19
- CSPI 51.81
- Support Level
- NMRA $0.72
- CSPI $11.84
- Resistance Level
- NMRA $0.85
- CSPI $13.24
- Average True Range (ATR)
- NMRA 0.07
- CSPI 0.72
- MACD
- NMRA -0.01
- CSPI 0.27
- Stochastic Oscillator
- NMRA 62.35
- CSPI 85.96
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About CSPI CSP Inc.
CSP Inc along with its subsidiaries develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments namely Technology Solutions, where the company focus on value-added reseller integrated solutions including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company design, manufacture and deliver products and services to customers that require specialized cyber security services, networking and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates its maximum revenue from the Americas.